vision loss

Device restores vision to patient with Stargardt diseaseAn artificial vision device (MyEye, OrCam) has helped a blind veteran regain his independence, according to the charity Scottish War Blinded.
How to target high-risk populations with behavioral healthHere are four of the top benefits of incorporating behavioral health management into care management plans for members with chronic conditions.
How ODs can help combat depression in glaucoma patientsResearchers have found a significant correlation between depression and visual field loss in patients with glaucoma, according to a study in Ophthalmology.
Be part of the vision rehab team for your pediatric patientsOphthalmologists who treat children with a diagnosis of vision loss can help with the near-term adjustment and long-term pursuit of goals by providing information about rehabilitation programs, support groups, and other resources.
Functional vision loss in children: What to say to parents, the patientFunctional vision loss in children is a relatively common problem. Although physicians may be hesitant to delve into conversations with children and parents when there is no evidence of organic disease, it is better to probe for cause of stress, anxiety, or depression stemming from issues with family, school, outside activities, or friends, and to identify for the patient and parents areas for attention that may be previously unknown or overlooked.
Triple macular carotenoid supplement provides greatest benefits for AMD patientsThe AREDS2 findings have empowered ophthalmologists to recommend appropriate supplements to reduce risk of visual loss in patients with AMD. In this article, the authors discuss the emerging revelation that the constituents of macular pigment enhance visual performance and explain how supplementation with all three macular carotenoids in a MZ:L:Z (mg) ratio of 10:10:2 can confer the greatest benefits.
Autoimmune retinopathy: While uncommon, viable option for unexplained vision lossOphthalmologists should suspect autoimmune retinopathy if a patient presents with an unexplained visual loss.
FDA follow-up confirms low risk of long-term vision loss secondary to ezogabine pigment changesFDA has issued a drug safety communication on GlaxoSmithKline's anti-seizure drug ezogabine (Potiga). Side effects of the the drug, which may include vision loss due to eye pigment change and skip discoloration, can be "adequately managed" by following the label, reports the FDA.
Decreased vision on the left side leads to hemianopia diagnosisA 39-year-old African-American female presented to The Eye Center at Southern College of Optometry with complaints of blurred vision, loss of side vision to the left, and trouble with mobility. S
Germanwings pilot may have had vision problemsRecent reports have revealed that 27-year-old Germanwings pilot, Andreas Lubitz, sought treatment for vision problems before he crashed a plane into the French Alps, killing himself and the 149 passengers and crewmembers.